AstraZeneca Crestor Ad Defends Safety, Re-Asserts Superiority Claims
Executive Summary
AstraZeneca's full-page ads responding to questions about the safety of Crestor (rosuvastatin) repeat the company's claim that the drug is more effective at lowering cholesterol than other statins
You may also be interested in...
To Crestor’s Foe, FDA Says Toxicity Is Low, But DTC Ads Must Go
FDA says AstraZeneca's Crestor is as safe as, if not safer than, other statins for a given LDL-lowering efficacy, but its ad campaign cannot claim superiority to Pfizer's Lipitor
To Crestor’s Foe, FDA Says Toxicity Is Low, But DTC Ads Must Go
FDA says AstraZeneca's Crestor is as safe as, if not safer than, other statins for a given LDL-lowering efficacy, but its ad campaign cannot claim superiority to Pfizer's Lipitor
Crestor Muscle Risk No Greater Than Other Statins, FDA Says; Death Reported
FDA's current view is that there is no greater risk for muscle injury with AstraZeneca's cholesterol lowering drug Crestor than with other statins, the agency said